Kathryn Flynn, PhD

Associate Professor

Locations

Department of Medicine
Division of Hematology and Oncology

Biography

Dr. Kathryn Flynn is an Associate Professor of Medicine at the Medical College of Wisconsin, Division of Hematology and Oncology. She is also the Senior Scientific Director for Patient-Reported Outcomes in the Center for International Blood and Marrow Transplant Research (CIBMTR). She was trained in sociology (BA, MS) and population health sciences (PhD).

Leadership Positions

Senior Scientific Director for Patient-Reported Outcomes Center for International Blood and Marrow Transplant Research

Research Interests

Dr. Flynn’s research focuses on the measure development and analysis of patient-reported outcomes as well as mixed methods approaches to understanding and improving patient-provider communication and patient decision making. She was a co-investigator in the PROMIS Network – NIH Roadmap initiative to standardize patient-reported outcomes measurement across diseases. She co-led development of the PROMIS Sexual Function and Satisfaction measure. She currently co-leads an NICHD R21 as well as a 14-site NCI-funded R01 examining clinical and patient-reported outcomes among patients with chronic myeloid leukemia who discontinue targeted therapies.

Patient-Reported Neuropsychiatric Outcomes of Long-Term Survivors after Chimeric Antigen Receptor T Cell Therapy.

(Ruark J, Mullane E, Cleary N, Cordeiro A, Bezerra ED, Wu V, Voutsinas J, Shaw BE, Flynn KE, Lee SJ, Turtle CJ, Maloney DG, Fann JR, Bar M.) Biol Blood Marrow Transplant. 2020 Jan;26(1):34-43 PMID: 31605820 PMCID: PMC6951812 SCOPUS ID: 2-s2.0-85075482768 10/13/2019
Reliability and validity of PROMIS® pediatric family relationships short form in children 8-17 years of age with chronic disease.

(Cox ED, Connolly JR, Palta M, Rajamanickam VP, Flynn KE.) Qual Life Res. 2020 Jan;29(1):191-199 PMID: 31401748 08/12/2019
A New Brief Clinical Assessment of Lower Urinary Tract Symptoms for Women and Men: LURN SI-10.

(Cella D, Smith AR, Griffith JW, Kirkali Z, Flynn KE, Bradley CS, Jelovsek JE, Gillespie BW, Helfand BT, Talaty P, Weinfurt KP, LURN Study Group.) J Urol. 2020 01;203(1):164-170 PMID: 31364922 PMCID: PMC6904437 SCOPUS ID: 2-s2.0-85076329208 08/01/2019
The association of pharmacy fill synchronization with breast cancer endocrine therapy adherence.

(Neuner JM, Fergestrom NM, Laud PW, Nattinger AB, Beyer KMM, Flynn KE, Pezzin LE.) Cancer. 2019 Nov 15;125(22):3960-3965 PMID: 31373689 SCOPUS ID: 2-s2.0-85074244186 08/03/2019
Sexual Orientation and Patient-Provider Communication About Sexual Problems or Concerns Among US Adults.

(Flynn KE, Whicker D, Lin L, Cusatis R, Nyitray A, Weinfurt KP.) J Gen Intern Med. 2019 Nov;34(11):2505-2511 PMID: 31452036 PMCID: PMC6848742 SCOPUS ID: 2-s2.0-85071493061 08/28/2019
Incorporating patient-generated contextual data into care: Clinician perspectives using the Consolidated Framework for Implementation Science.

(Holt JM, Cusatis R, Asan O, Williams J, Nukuna S, Flynn KE, Moore J, Crotty BH.) Healthc (Amst). 2019 Aug 21:100369 PMID: 31445878 08/26/2019
A new outcome measure for LUTS: Symptoms of Lower Urinary Tract Dysfunction Research Network Symptom Index-29 (LURN SI-29) questionnaire.

(Cella D, Smith AR, Griffith JW, Flynn KE, Bradley CS, Gillespie BW, Kirkali Z, Talaty P, Jelovsek JE, Helfand BT, Weinfurt KP, LURN Study Group.) Neurourol Urodyn. 2019 08;38(6):1751-1759 PMID: 31225927 PMCID: PMC6660359 SCOPUS ID: 2-s2.0-85069691417 06/22/2019
Too much time? Time use and fertility-specific quality of life among men and women seeking specialty care for infertility.

(Cusatis R, Fergestrom N, Cooper A, Schoyer KD, Kruper A, Sandlow J, Strawn E, Flynn KE.) BMC Psychol. 2019 Jul 09;7(1):45 PMID: 31288855 PMCID: PMC6617689 SCOPUS ID: 2-s2.0-85068877996 07/11/2019
Sexual Dysfunction and Reproductive Concerns in Young Men Diagnosed With Testicular Cancer: An Observational Study.

(Ljungman L, Eriksson LE, Flynn KE, Gorman JR, Ståhl O, Weinfurt K, Wiklander M, Lampic C, Wettergren L.) J Sex Med. 2019 Jul;16(7):1049-1059 PMID: 31255211 SCOPUS ID: 2-s2.0-85067892716 07/01/2019
Baseline patient-reported outcomes in light-chain amyloidosis patients enrolled on an interventional clinical trial.

(D'Souza A, Hari P, Pasquini M, Jacobsen K, Flynn KE.) Amyloid. 2019;26(sup1):87-88 PMID: 31343353 SCOPUS ID: 2-s2.0-85069630470 07/26/2019
The impact of patient-generated contextual data on communication in clinical practice: A qualitative assessment of patient and clinician perspectives.

(Cusatis R, Holt JM, Williams J, Nukuna S, Asan O, Flynn KE, Neuner J, Moore J, Makoul G, Crotty BH.) Patient Educ Couns. 2019 Oct 30 PMID: 31744702 SCOPUS ID: 2-s2.0-85075460878 11/21/2019
Exploring health behaviors, quality of life, and support needs in African-American prostate cancer survivors: a pilot study to support future interventions.

(Stolley MR, Sheean P, Matthews L, Banerjee A, Visotcky A, Papanek P, Woodley L, Flynn KE.) Support Care Cancer. 2019 Nov 08 PMID: 31705377 SCOPUS ID: 2-s2.0-85074866826 11/11/2019

Kathryn Flynn, PhD